226 related articles for article (PubMed ID: 19339053)
1. A pilot study of impulsivity and compulsivity in pathological gambling.
Blanco C; Potenza MN; Kim SW; Ibáñez A; Zaninelli R; Saiz-Ruiz J; Grant JE
Psychiatry Res; 2009 May; 167(1-2):161-8. PubMed ID: 19339053
[TBL] [Abstract][Full Text] [Related]
2. Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS).
Pallanti S; DeCaria CM; Grant JE; Urpe M; Hollander E
J Gambl Stud; 2005; 21(4):431-43. PubMed ID: 16311876
[TBL] [Abstract][Full Text] [Related]
3. A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling.
Kim SW; Grant JE; Adson DE; Shin YC; Zaninelli R
J Clin Psychiatry; 2002 Jun; 63(6):501-7. PubMed ID: 12088161
[TBL] [Abstract][Full Text] [Related]
4. The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study.
Kim SW; Grant JE; Potenza MN; Blanco C; Hollander E
Psychiatry Res; 2009 Mar; 166(1):76-84. PubMed ID: 19200607
[TBL] [Abstract][Full Text] [Related]
5. Nefazodone treatment of pathological gambling: a prospective open-label controlled trial.
Pallanti S; Baldini Rossi N; Sood E; Hollander E
J Clin Psychiatry; 2002 Nov; 63(11):1034-9. PubMed ID: 12444818
[TBL] [Abstract][Full Text] [Related]
6. Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial.
McElroy SL; Nelson EB; Welge JA; Kaehler L; Keck PE
J Clin Psychiatry; 2008 Mar; 69(3):433-40. PubMed ID: 18251624
[TBL] [Abstract][Full Text] [Related]
7. Latent class analysis of gambling subtypes and impulsive/compulsive associations: Time to rethink diagnostic boundaries for gambling disorder?
Chamberlain SR; Stochl J; Redden SA; Odlaug BL; Grant JE
Addict Behav; 2017 Sep; 72():79-85. PubMed ID: 28384607
[TBL] [Abstract][Full Text] [Related]
8. Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation.
Grant JE; Potenza MN
Int Clin Psychopharmacol; 2006 Jul; 21(4):203-9. PubMed ID: 16687991
[TBL] [Abstract][Full Text] [Related]
9. Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study.
Grant JE; Chamberlain SR; Odlaug BL; Potenza MN; Kim SW
Psychopharmacology (Berl); 2010 Dec; 212(4):603-12. PubMed ID: 20721537
[TBL] [Abstract][Full Text] [Related]
10. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?
Hollander E; Pallanti S; Allen A; Sood E; Baldini Rossi N
Am J Psychiatry; 2005 Jan; 162(1):137-45. PubMed ID: 15625212
[TBL] [Abstract][Full Text] [Related]
11. Short-term single-blind fluvoxamine treatment of pathological gambling.
Hollander E; DeCaria CM; Mari E; Wong CM; Mosovich S; Grossman R; Begaz T
Am J Psychiatry; 1998 Dec; 155(12):1781-3. PubMed ID: 9842795
[TBL] [Abstract][Full Text] [Related]
12. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.
Grant JE; Potenza MN; Hollander E; Cunningham-Williams R; Nurminen T; Smits G; Kallio A
Am J Psychiatry; 2006 Feb; 163(2):303-12. PubMed ID: 16449486
[TBL] [Abstract][Full Text] [Related]
13. Sertraline treatment of pathological gambling: a pilot study.
Saiz-Ruiz J; Blanco C; Ibáñez A; Masramon X; Gómez MM; Madrigal M; Díez T
J Clin Psychiatry; 2005 Jan; 66(1):28-33. PubMed ID: 15669885
[TBL] [Abstract][Full Text] [Related]
14. Divergent validity of measures of cognitive distortions, impulsivity, and time perspective in pathological gambling.
MacKillop J; Anderson EJ; Castelda BA; Mattson RE; Donovick PJ
J Gambl Stud; 2006; 22(3):339-54. PubMed ID: 16826455
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of geriatric patients seeking medication treatment for pathologic gambling disorder.
Grant JE; Kim SW; Brown E
J Geriatr Psychiatry Neurol; 2001; 14(3):125-9. PubMed ID: 11563435
[TBL] [Abstract][Full Text] [Related]
16. Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial.
Grant JE; Kim SW; Potenza MN; Blanco C; Ibanez A; Stevens L; Hektner JM; Zaninelli R
Int Clin Psychopharmacol; 2003 Jul; 18(4):243-9. PubMed ID: 12817159
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges.
Grant JE; Kim SW; Hartman BK
J Clin Psychiatry; 2008 May; 69(5):783-9. PubMed ID: 18384246
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis, neurobiology, and treatment of pathological gambling.
DeCaria CM; Hollander E; Grossman R; Wong CM; Mosovich SA; Cherkasky S
J Clin Psychiatry; 1996; 57 Suppl 8():80-3; discussion 83-4. PubMed ID: 8698687
[TBL] [Abstract][Full Text] [Related]
19. Comorbidity of impulse control disorders in pathological gamblers.
Grant JE; Kim SW
Acta Psychiatr Scand; 2003 Sep; 108(3):203-7. PubMed ID: 12890275
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological treatments of pathological gambling.
Hollander E; Sood E; Pallanti S; Baldini-Rossi N; Baker B
J Gambl Stud; 2005; 21(1):99-110. PubMed ID: 15789195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
